Flexibility of the hepatic zonation of carbon and nitrogen fluxes linked to lactate and pyruvate transformations in the presence of ammonia.
It has been proposed that key enzymes of ureagenesis and the alanine aminotransferase activity predominate in periportal hepatocytes. However, ureagenesis from alanine, when measured in the perfused liver, did not show periportal predominance and even the release of the direct products of alanine transformation, lactate and pyruvate, was higher in perivenous cells. An alternative way of analyzing the functional distributions of alanine aminotransferase and the urea cycle along the hepatic acini would be to measure alanine and urea production from precursors such as lactate or pyruvate plus ammonia. In the present work these aspects were investigated in the bivascularly perfused rat liver. The results of the present study confirm that gluconeogenesis and the associated oxygen uptake tend to predominate in the periportal region. Alanine synthesis from lactate and pyruvate plus ammonia, however, predominated in the perivenous region. Furthermore, no predominance of ureagenesis in the periportal region was found, except for conditions of high ammonia concentrations plus oxidizing conditions induced by pyruvate. These observations corroborate the view that data on enzyme activity or expression alone cannot be extrapolated unconditionally to the living cell. The current view of the hepatic ammonia-detoxifying system proposes that the small perivenous fraction of glutamine synthesizing perivenous cells removes a minor fraction of ammonia that escapes from ureagenesis in periportal cells. However, since urea synthesis occurs at high rates in all hepatocytes with the possible exclusion of those cells not possessing carbamoyl-phosphate synthase, it is probable that ureagenesis is equally important as an ammonia-detoxifying mechanism in the perivenous region.
Comar
Jurandir Fernando
JF
Laboratory of Liver Metabolism, Dept. of Biochemistry, Univ. of Maringá, 87020900 Maringá, Brazil.
Suzuki-Kemmelmeier
Fumie
F
Nascimento
Ecio Alves
EA
Bracht
Adelar
A
D000409:Alanine / Q000378:metabolism; D000641:Ammonia / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002244:Carbon / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D007773:Lactates / Q000378:metabolism*; D008099:Liver / Q000098:blood supply / Q000502:physiology*; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D009584:Nitrogen / Q000378:metabolism*; D010477:Perfusion / Q000379:methods; D019289:Pyruvic Acid / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014508:Urea / Q000378:metabolism
D007773:Lactates; D018698:Glutamic Acid; D002244:Carbon; D000641:Ammonia; D019289:Pyruvic Acid; D014508:Urea; D009584:Nitrogen; D000409:Alanine